Index microvascular resistance (IMR) in heart transplant patients (IMR-HT study): Study protocol
PLOS One · 2025
DOI: 10.1371/journal.pone.0315053 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift PLOS One, 2025. Verfasst von Ainhoa Pérez-Guerrero und 18 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology, Miguel Servet University Hospital, Zaragoza, Spain. Hauptthemen laut MEDLINE: Graft Rejection, Heart Transplantation, Microvessels, Vascular Resistance. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Acute allograft rejection (AAR) is an important cause of morbi mortality in heart transplant (HT) patients, particularly during the first year. Endomyocardial biopsy (EMB) is the “gold standard” to guide post- heart transplantation treatment. However, it is associated with complications that can be potentially serious. The index of microvascular resistance (IMR) is a specific physiological parameter used to assess microvascular function. Invasive coronary assessment has been shown to be both feasible and safe. Detection of coronary microvascular dysfunction (MCD) by IMR may help to identify high risk HT patients. In fact, an increased IMR measured early after HT has been associated with AAR, higher all-cause mortality and adverse cardiac events. A high IMR value early after HT may identify patients at higher risk who require increased surveillance or adjustments in immunosuppressive therapy. Conversely, a low IMR value may support reducing the number of EMBs. Our aim is to evaluate IMR in heart transplant patients within the first year. Changes in management after knowing IMR values and prognostic implications of IMR in a long term follow up will also be assessed. Study design The IMR-HT study (NCT 06656065) is a multicenter, prospective study that will include post-HT consecutive stable patients undergoing coronary physiological assessment in the first three months and one year. Cardiac adverse events will be evaluated at one year for up to five years. A clinical management algorithm is proposed: after knowing IMR values the physician will be able to reduce the number of biopsies established in each center protocol or modify immunosuppression therapy.
Conclusions
IMR values may vary within the first year after heart transplant. IMR assessment will be useful to identify high risk heart transplant patients, leading to possible changes in management and prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Cardiology, Miguel Servet University Hospital, Zaragoza, Spain.
- Clínico Lozano Blesa University Hospital, Zaragoza, Spain.
- Aragon Health Research Institute (IIS Aragon), Zaragoza, Spain.
- La Fe University Hospital, Valencia, Spain.
- Center for cardiovascular biomedical research (CIBER-CV), Madrid, Spain.
- Hospital Clínic, Cardiovascular Clinic Institute, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
ORCID-Profile: Ainhoa Pérez-Guerrero, Jean Paul Vilchez-Tschischke, Jose Luis Diez Gil, María Dolores García-Cosio, Diego Rangel Sousa, Georgina Fuertes Ferre
Zitieren
APA
Pérez-Guerrero, A., Vilchez-Tschischke, J. P., Bonet, L. A., Diez Gil, J. L., Peiró, T. B., Brugaletta, S., Gomez-Lara, J., Costello, J. G., Antuña, P., Fernández, V. A., Cebada, F. S., García-Cosio, M. D., Lesmes, F. H., Granados, A. L., López-Palop, R., Garrido, I. P., Cardenal Piris, R. M., Sousa, D. R., & Fuertes Ferre, G. (2025). Index microvascular resistance (IMR) in heart transplant patients (IMR-HT study): Study protocol. PLOS One. https://doi.org/10.1371/journal.pone.0315053
Vancouver
Pérez-Guerrero A, Vilchez-Tschischke JP, Bonet LA, Diez Gil JL, Peiró TB, Brugaletta S, et al. Index microvascular resistance (IMR) in heart transplant patients (IMR-HT study): Study protocol. PLOS One. 2025. doi:10.1371/journal.pone.0315053
BibTeX
@article{PrezGuerrero2025,
author = {Pérez-Guerrero, Ainhoa and Vilchez-Tschischke, Jean Paul and Bonet, Luis Almenar and Diez Gil, Jose Luis and Peiró, Teresa Blasco and Brugaletta, Salvatore and Gomez-Lara, Josep and Costello, José González and Antuña, Paula and Fernández, Vanesa Alonso and Cebada, Fernando Sarnago and García-Cosio, María Dolores and Lesmes, Francisco Hidalgo and Granados, Amador López and López-Palop, Ramón and Garrido, Iris Paula and Cardenal Piris, Rosa María and Sousa, Diego Rangel and Fuertes Ferre, Georgina},
title = {Index microvascular resistance (IMR) in heart transplant patients (IMR-HT study): Study protocol},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0315053}
}
EUVIMED